Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
24 Apr 24
8-K
Results of Operations and Financial Condition
23 Apr 24
PX14A6G
Letter to shareholders
11 Apr 24
DEFA14A
Additional proxy soliciting materials
5 Apr 24
DEF 14A
Definitive proxy
5 Apr 24
PRE 14A
Preliminary proxy
25 Mar 24
10-K
2023 FY
Annual report
22 Feb 24
8-K
Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share
1 Feb 24
8-K
Quest Diagnostics Prices $750 Million of Senior Notes
1 Nov 23
424B2
Prospectus for primary offering
31 Oct 23
FWP
Free writing prospectus
30 Oct 23
424B2
Prospectus for primary offering
30 Oct 23
S-8
Registration of securities for employees
27 Oct 23
10-Q
2023 Q3
Quarterly report
25 Oct 23
8-K
Updates Guidance for Full Year 2023
24 Oct 23
8-K
Departure of Directors or Certain Officers
29 Sep 23
10-Q
2023 Q2
Quarterly report
27 Jul 23
8-K
Updates Guidance for Full Year 2023
26 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
19 May 23
10-Q
2023 Q1
Quarterly report
28 Apr 23
8-K
Updates Guidance for Full Year 2023
27 Apr 23
PX14A6G
Letter to shareholders
10 Apr 23
DEFA14A
Additional proxy soliciting materials
6 Apr 23
DEF 14A
Definitive proxy
6 Apr 23
8-K
Quest Diagnostics to Discuss Strategic Priorities to Drive Growth and Create Shareholder Value at 2023 Investor Day
17 Mar 23
8-K
Quest Diagnostics Board of Directors Elects James E. Davis Chairman of the Board
7 Mar 23
10-K
2022 FY
Annual report
21 Feb 23
8-K
Results of Operations and Financial Condition
2 Feb 23
8-K
Departure of Directors or Certain Officers
18 Nov 22
8-K
Quest Diagnostics Completes Leadership Succession as Jim Davis Becomes CEO
1 Nov 22
8-K
Departure of Directors or Certain Officers
28 Oct 22
10-Q
2022 Q3
Quarterly report
21 Oct 22
8-K
Results of Operations and Financial Condition
20 Oct 22
S-3ASR
Automatic shelf registration
25 Jul 22
10-Q
2022 Q2
Quarterly report
22 Jul 22
8-K
Results of Operations and Financial Condition
21 Jul 22
8-K/A
Departure of Directors or Certain Officers
1 Jul 22
8-K
Quest Diagnostics Names Sam Samad Executive Vice President and Chief Financial Officer
14 Jun 22
8-K
Departure of Directors or Certain Officers
25 May 22
8-K
Amendments to Articles of Incorporation or Bylaws
20 May 22
Latest ownership filings
4
KARTHIK KUPPUSAMY
1 May 24
144
Notice of proposed sale of securities
29 Apr 24
4
Vicky B Gregg
26 Apr 24
4
KARTHIK KUPPUSAMY
26 Apr 24
4
Patrick Plewman
26 Apr 24
4
SAM SAMAD
26 Apr 24
144
Notice of proposed sale of securities
25 Apr 24
4
TIMOTHY M RING
3 Apr 24
4
MARK E DELANEY
28 Mar 24
4
Patrick Plewman
28 Mar 24
4
Patrick Plewman
1 Mar 24
4
Catherine T. Doherty
1 Mar 24
4
MICHAEL E PREVOZNIK
1 Mar 24
4
KARTHIK KUPPUSAMY
1 Mar 24
4
SAM SAMAD
1 Mar 24
4
J. E. Davis
1 Mar 24
4
MARK A GARDNER
1 Mar 24
4
MICHAEL J DEPPE
1 Mar 24
4
MARK E DELANEY
1 Mar 24
144
Notice of proposed sale of securities
29 Feb 24
144
Notice of proposed sale of securities
29 Feb 24
144
Notice of proposed sale of securities
28 Feb 24
4
J. E. Davis
27 Feb 24
4
MICHAEL E PREVOZNIK
27 Feb 24
4
Patrick Plewman
27 Feb 24
4
Catherine T. Doherty
27 Feb 24
4
KARTHIK KUPPUSAMY
27 Feb 24
4
MICHAEL J DEPPE
27 Feb 24
4
Patrick Plewman
23 Feb 24
4
J. E. Davis
23 Feb 24
4
MICHAEL E PREVOZNIK
23 Feb 24
4
Vicky B Gregg
23 Feb 24
4
KARTHIK KUPPUSAMY
23 Feb 24
4
Catherine T. Doherty
23 Feb 24
4
MICHAEL J DEPPE
23 Feb 24
144
Notice of proposed sale of securities
23 Feb 24
144
Notice of proposed sale of securities
22 Feb 24
144
Notice of proposed sale of securities
22 Feb 24
4
J. E. Davis
16 Feb 24
4
MARK A GARDNER
16 Feb 24